New Trends for Tuberculosis in R&D

Currently tuberculosis (TB) control methods, does not effectively block transmission of TB, and do not include a competent vaccine.  Research studies show the mass vaccination campaigns using new vaccines could prevent14.5 million deaths from 2015 and 85.9 million new cases through 2050 in southern Asia alone. After many years, it now includes 7 vaccine candidates that are being tested in humans. Two non-replicating viral vectored vaccines have very recently entered the first phase IIb efficacy trial in infants (the first such trial in 80 years) and in human immunodeficiency virus-infected adults. Science is improving, but the scientific advancements need to be guided by political mobilization to ensure that the resources are available to produce, manufacture, and distribute the new vaccines and thus, save billions of lives throughout the world. Researchers are utilizing information retrieved from the entire sequence from the genome of M. tuberculosis and from new genetic & physiological methods to identify targets in M. tuberculosis that will aid in the development of these greatly needed antitubercular agents. 

Goals of TB therapy:

1.      Simplify and shorten the treatment of latent, active, drug-sensitive TB

2.      Improve efficiency, safety and shorten duration of therapy for drug-resistant disease.

3.      Develop drugs for those with TB who are co-infected with HIV that can be readily given with ARVs.



























































  • Exemplify the biological mechanisms of mycobacterial latency and persistence.
  • Develop new preclinical ways for identifying optimized drug combinations and new clinical and regulatory approaches for testing drug combinations in phase 2 and 3 clinical trials.
  • Discover and develop new drugs that have unusual mechanisms of action and are effective against unremitting bacilli.
  • Develop and validate animal models that accurately predict human treatment duration.
  • Strengthen capacity to conduct clinical trials in high-burden countries.
  • Develop and validate biomarkers and proxy endpoints that predict efficiency and thereby shorten clinical trial duration.

Are you interested in

Terms and Conditions

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to finance@conferenceseries.com 



Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Conference Series/OMICS International event which must occur within one year from the date of cancellation.

Postponement

 

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another event which must occur within one year from the date of postponement.

 

Transfer of registration

 

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to finance@conferenceseries.com . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

 

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy

 

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

  1.  
Copyright © 2017-2018 Allied Academies, All Rights Reserved.